Pen device
Latest Socrates Health Solutions, Inc. Patents:
Description
The broken lines depict portions of the pen device that form no part of the claimed design.
Claims
The ornamental design for a pen device, as shown and described.
Referenced Cited
U.S. Patent Documents
Other references
4627445 | December 9, 1986 | Garcia et al. |
5029583 | July 9, 1991 | Meserol et al. |
5378233 | January 3, 1995 | Haber et al. |
D371194 | June 25, 1996 | Marston et al. |
D399951 | October 20, 1998 | Drach |
6302855 | October 16, 2001 | Lav |
D543273 | May 22, 2007 | Young et al. |
D547859 | July 31, 2007 | Choi |
D590063 | April 7, 2009 | Garthoff et al. |
7988660 | August 2, 2011 | Byland |
D700319 | February 25, 2014 | Tani |
D768856 | October 11, 2016 | Harkin et al. |
D847328 | April 30, 2019 | Kriesel |
D861170 | September 24, 2019 | Smith |
10548537 | February 4, 2020 | Brauer |
D910836 | February 16, 2021 | Sandberg |
20070244438 | October 18, 2007 | Perez |
20080306434 | December 11, 2008 | Dobbles et al. |
20100256990 | October 7, 2010 | Horiguchi et al. |
20100268052 | October 21, 2010 | Asama et al. |
20120046606 | February 23, 2012 | Arefieg |
20160374557 | December 29, 2016 | Bakhshi et al. |
20190167139 | June 6, 2019 | Bardy |
20190183434 | June 20, 2019 | Sjolund |
- Notice of Allowance on U.S. Appl. No. 29/637,436 dated May 8, 2019.
Patent History
Patent number: D926989
Type: Grant
Filed: Aug 8, 2019
Date of Patent: Aug 3, 2021
Assignee: Socrates Health Solutions, Inc. (Dallas, TX)
Inventors: Scott J. Smith (Dallas, TX), Douglas F. Sutherland (Luxembourg), Valentin Korman (Huntsville, AL), Tyde Meadows (Hartselle, AL)
Primary Examiner: Anhdao Doan
Application Number: 29/701,068
Type: Grant
Filed: Aug 8, 2019
Date of Patent: Aug 3, 2021
Assignee: Socrates Health Solutions, Inc. (Dallas, TX)
Inventors: Scott J. Smith (Dallas, TX), Douglas F. Sutherland (Luxembourg), Valentin Korman (Huntsville, AL), Tyde Meadows (Hartselle, AL)
Primary Examiner: Anhdao Doan
Application Number: 29/701,068
Classifications
Current U.S. Class:
Hematological Or Intravenous Treatment (41) (D24/169)